Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

NCT05038982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Prurigo Nodularis
Pruritus
Chronic Pruritus
Chronic Prurigo
Skin Diseases

Interventions

DRUG: Abrocitinib

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]